about
Emerging risk biomarkers in cardiovascular diseases and disordersCirculating miR-30d Predicts Survival in Patients with Acute Heart Failure.Emerging biomarkers in heart failure and cardiac cachexiaUndiagnosed airflow limitation is common in patients with coronary artery disease and associated with cardiac stress.Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity-2.Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.Galectin-3 levels relate in children to total body fat, abdominal fat, body fat distribution, and cardiac size.
P2860
Q28081614-CEBE9C65-EF65-4573-BA69-C61F2B221B3BQ33902036-7A18A277-7D1D-44B5-9169-5EC89412498FQ34836097-328F217A-95C6-4B4A-8437-B70FDEBBE7ADQ40383327-DB93C045-B7B1-44F7-AE0E-A4E5DAE01A63Q47138839-BBB11517-FDA7-4A7E-B302-CC9B94A1CAA2Q47815486-20998B91-0AFC-407B-9DE9-9FA307E4306EQ48043409-10D6B055-65EB-498A-9471-0F16EB79C7B4
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Emerging biomarkers for acute heart conditions.
@en
type
label
Emerging biomarkers for acute heart conditions.
@en
prefLabel
Emerging biomarkers for acute heart conditions.
@en
P1476
Emerging biomarkers for acute heart conditions.
@en
P2093
Allan S Jaffe
Vlad C Vasile
P304
P356
10.1097/HCO.0000000000000077
P577
2014-07-01T00:00:00Z